Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
ETFs
Top 10 ETF Picks for 2020
By ETF Focus
Jan 24, 2020 1:05 PM EST
STOCKS
Shares of CRISPR Therapeutics Fall in After Hours Trading on Share Offering
By Tom Bemis
Nov 19, 2019 8:37 PM EST
INVESTING
3 Investments You Are Probably Not Considering, But Should Be
By Brian Sozzi
Jul 25, 2018 6:16 PM EDT
STOCKS
Biogen Sparks Hope on Treating Alzheimer's Disease: Everything You Must Know
By Brian Sozzi
Jul 7, 2018 11:17 AM EDT
ETFs
Investors With an Appetite for Risk Could Find Big Gains In Biotech ETFs
By Alexander Nicoll
Jul 4, 2018 8:40 AM EDT
STOCKS
Biohaven Pharma's New Migraine Drug Shows Promise in Late-Stage Test Results
By Alexander Nicoll
Jun 28, 2018 12:30 PM EDT
STOCKS
New Opportunities in Biotech: Cramer's 'Off the Charts'
By Tom Bemis
Mar 21, 2018 7:28 AM EDT
JIM CRAMER
Chopping a Way Back for the Bull: Cramer's 'Mad Money' Recap
By Scott Rutt
Mar 21, 2018 6:29 AM EDT
STOCKS
Best Biotech Stock Trades and Mergers to Watch in 2018
By Ellen Chang
Jan 2, 2018 3:17 PM EST
STOCKS
4 Signs the Bull Market in Stocks Remains Incredibly Strong
By Kinsey Grant
Dec 12, 2017 11:41 AM EST
FUTURES
Wall Street Finishes Monday in the Green After Two Weeks of Losses
By Kinsey Grant
Nov 20, 2017 4:10 PM EST
FUTURES
Consumer and Industrial Stocks Push Dow Higher After Two Weeks of Losses
By Kinsey Grant
Nov 20, 2017 1:48 PM EST
INVESTING
Celgene Disappoints; How to Praise, How to Blame: Doug Kass' Views
By Doug Kass
Oct 30, 2017 1:00 AM EDT
STOCKS
Celgene's Steep Decline Welcome News for Short Sellers
By Giovanni Bruno
Oct 26, 2017 2:33 PM EDT
FUTURES
Positive Earnings Drive Dow to New Record in Best Performance in a Month
By Keris Alison Lahiff
Oct 24, 2017 4:01 PM EDT
FUTURES
Dow Rises 200 Points With Records in Grasp After Caterpillar, 3M Earnings
By Keris Alison Lahiff
Oct 24, 2017 1:31 PM EDT
FUTURES
UnitedHealth and Johnson & Johnson Lead Bruised Healthcare Sector to Gains
By Keris Alison Lahiff
Oct 17, 2017 11:07 AM EDT
INVESTING
Allergan Price Target Reduction; Lacing Up Nike: Doug Kass' Views
By Doug Kass
Oct 2, 2017 1:00 AM EDT
STOCKS
3 Biotech Stocks With 10% Upside or More -- One Could Even Double
By Bret Kenwell
Jul 11, 2017 10:23 AM EDT
STOCKS
Here's the Latest on Four New Biotech IPOs
By Melissa Angell
Jul 3, 2017 1:02 PM EDT
FUTURES
Another Steep Selloff in Tech Wipes Out Nasdaq's June Gains
By Keris Alison Lahiff
Jun 29, 2017 8:00 PM EDT
FUTURES
Nasdaq Tanks Nearly 2%, On Track for Fourth Worst Day of 2017
By Keris Alison Lahiff
Jun 29, 2017 3:31 PM EDT
STOCKS
Celgene, Gilead and Other Red-Hot Biotech Stocks Just Got Run Over
By Giovanni Bruno
Jun 29, 2017 2:25 PM EDT
FUTURES
Stocks Mixed as FAANG Stocks Fluctuate, SCOTUS Agrees to Hear Travel Ban
By Keris Alison Lahiff
Jun 26, 2017 10:53 AM EDT
FUTURES
Stock Futures Point Higher as Healthcare Climbs Ahead of Senate Vote
By Keris Alison Lahiff
Jun 26, 2017 8:40 AM EDT